Trial Profile
Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2015
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Acute coronary syndromes; Cardiovascular disorders; Embolism and thrombosis
- Focus Pharmacodynamics
- 27 Jun 2012 New trial record